These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 733550)

  • 41. Proceedings of the Second Symposium on Labetalol, London, March 1979.
    Br J Clin Pharmacol; 1979; 8(Suppl 2):89S-244S. PubMed ID: 526409
    [No Abstract]   [Full Text] [Related]  

  • 42. Double-blind trial of labetalol.
    Kane J; Gregg I; Richards DA
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):737-41. PubMed ID: 791329
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Comparison of metroprolol and labetalol. Antihypertensive activity at rest and during exertion and effect on some noninvasive parameters of cardiovascular function].
    Demarchi PG; Mancini A; Brignole M; Astengo D; Bertulla A
    Minerva Cardioangiol; 1981 Dec; 29(12):719-28. PubMed ID: 7038536
    [No Abstract]   [Full Text] [Related]  

  • 44. The electrophysiological effects of intravenous labetalol in man.
    Harley A; Coverdale HA
    Eur J Clin Pharmacol; 1981; 20(4):241-4. PubMed ID: 7308279
    [No Abstract]   [Full Text] [Related]  

  • 45. [Anti-angina and hemodynamic action of labetalol in angina patients].
    Sharaeva ML
    Vrach Delo; 1987 May; (5):57-9. PubMed ID: 3617687
    [No Abstract]   [Full Text] [Related]  

  • 46. [Action of labetalol on heart rate, arterial pressure and systolic time intervals at rest and during exercise in hypertensive subjects].
    Cherchi A; Raffo M; Sau F; Seguro C; Pirisi R
    Boll Soc Ital Cardiol; 1978; 23(1):158-76. PubMed ID: 754770
    [No Abstract]   [Full Text] [Related]  

  • 47. [Hemodynamic effects of a new hypertensive agent (2',5'-dimethoxyphenyl-2 glycinamido-ethanol-1-hydrochlorid) following intravenous administration].
    Hitzenberger G; Mösslacher H; Slany J
    Int J Clin Pharmacol; 1973 Jul; 7(4):323-7. PubMed ID: 4580043
    [No Abstract]   [Full Text] [Related]  

  • 48. [Labetalol for the management of hypertensive crises during surgery of cerebral aneurysm; a haemodynamic study (author's transl)].
    Lüben V; Rieder W; Zierski J; Hempelmann G
    Anasth Intensivther Notfallmed; 1981 Aug; 16(4):184-7. PubMed ID: 7294326
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The cardiovascular and uterine effects of labetolol in conscious normotensive pregnant rats [proceedings].
    Whalley ET
    Br J Pharmacol; 1977 Nov; 61(3):505P. PubMed ID: 588847
    [No Abstract]   [Full Text] [Related]  

  • 50. The effect of labetalol on the cardiovascular, hyperglycaemic and adrenocortical responses to surgery.
    Child CS
    Anaesthesia; 1984 Dec; 39(12):1192-6. PubMed ID: 6517247
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 7. New horizons in beta-adrenoceptor blockade therapy: labetalol.
    Frishman W; Halprin S
    Am Heart J; 1979 Nov; 98(5):660-5. PubMed ID: 386753
    [No Abstract]   [Full Text] [Related]  

  • 52. The hemodynamic effects of intravenous labetalol for postoperative hypertension.
    Orlowski JP; Vidt DG; Walker S; Haluska JF
    Cleve Clin J Med; 1989; 56(1):29-34. PubMed ID: 2731325
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The safety of cumulative doses of labetalol in perioperative hypertension.
    Cosentino F; Vidt DG; Orlowski JP; Shiesley D; Little JR
    Cleve Clin J Med; 1989 Jun; 56(4):371-6. PubMed ID: 2743552
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of labetalol on lipid and carbohydrates metabolism.
    Pagnan A; Pessina AC; Hlede M; Zanetti G; Dal Palu' C
    Pharmacol Res Commun; 1979 Mar; 11(3):227-36. PubMed ID: 223175
    [No Abstract]   [Full Text] [Related]  

  • 55. [Effect of labetalol on hemodynamics and oxygen consumption in patients in the early period of myocardial infarction].
    Gvatua NA; Mironova OV; Sirenko IuN; Tolstopiatov SM
    Kardiologiia; 1990 Apr; 30(4):30-3. PubMed ID: 2203928
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Does labetalol increase excretion of urinary catecholamines?
    Hamilton CA; Jones DH; Dargie HJ; Reid JL
    Br Med J; 1978 Sep; 2(6140):800. PubMed ID: 698739
    [No Abstract]   [Full Text] [Related]  

  • 57. Labetalol and lipids.
    McGonigle RJ; Williams L; Murphy MJ; Parsons V
    Lancet; 1981 Jan; 1(8212):163. PubMed ID: 6109848
    [No Abstract]   [Full Text] [Related]  

  • 58. Urinary catecholamines and labetalol.
    Preziosi P; Pisanti N; Brevetti G; Paudice G; Moerman EJ; De Schaepdryver AF
    Arch Int Pharmacodyn Ther; 1978 Dec; 236(2):317-9. PubMed ID: 747482
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of labetalol, an alpha-and beta-adrenoceptor antagonist, on gastric acid and gastrin secretion in man.
    Caldara R; Rampini P; Piepoli V; Borzoi M
    Br J Clin Pharmacol; 1982 Nov; 14(5):744-6. PubMed ID: 7138756
    [No Abstract]   [Full Text] [Related]  

  • 60. Labetalol and urinary catecholamines.
    Harris D; Richards DA
    Br Med J; 1977 Dec 24-31; 2(6103):1673. PubMed ID: 589414
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.